Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | USP14 | P54578 | 1/20 | 0.30 |
| ▸ | RPA1 | P27694 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12412796 | 0.90 | SMN1; SMN2 (0.33) | HTTPOLBBCL2L1MCL1SMN1; SMN2 | |
| SCHEMBL12412797 | 0.89 | HTT (0.32) | HTTPOLBBCL2L1MCL1CYP19A1 | |
| SCHEMBL12413055 | 0.89 | HTT (0.32) | HTTSMN1; SMN2USP14 | |
| SCHEMBL12412887 | 0.87 | USP14 (0.31) | HTTPOLBBCL2L1MCL1CYP19A1 | |
| SCHEMBL12412973 | 0.85 | USP14 (0.33) | HTTPOLBSMN1; SMN2USP14 | |
| SCHEMBL12413031 | 0.85 | SMN1; SMN2 (0.33) | HTTPOLBBCL2L1MCL1SMN1; SMN2 | |
| SCHEMBL12412937 | 0.84 | SMN1; SMN2 (0.35) | HTTPOLBBCL2L1MCL1SMN1; SMN2 | |
| SCHEMBL12413058 | 0.84 | HTT (0.40) | HTTPOLBCYP19A1SMN1; SMN2NPC1 | |
| SCHEMBL12412830 | 0.84 | USP14 (0.32) | HTTPOLBBCL2L1MCL1CYP19A1 | |
| SCHEMBL12503776 | 0.83 | HTT (0.38) | HTTPOLBBCL2L1MCL1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SCLY, MSRB3, SOD1 | HTT 4130/4885POLB 1411/4885BCL2L1 2064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.